GCTK

GlucoTrack Inc

1.11

Oct 05 • 3:59 PM ET -0.10 (-8.26%)

1.12

Aftermarket • 7:47 PM ET +0.01 (0.89%)

Healthcare Medical Devices USA Nano NASD

Peers: CUPR LUCY NXGL BNGO FEMY RGNT RVP ZJYL HBIO MLSS

Scroll to Statements

Index	-
Market Cap	1.13M
Enterprise Value	1.97M
Income	-15.95M
Sales	0.00M
Book/sh	-4.17
Cash/sh	1.10
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	15
IPO	Apr 25, 2013

P/E	-
Forward P/E	-
PEG	-
P/S	-
P/B	-
P/C	1.01
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	0.46
Current Ratio	0.46
Debt/Eq	-
LT Debt/Eq	-
Option/Short	No / Yes

EPS (ttm)	-180.43
EPS next Y	-
EPS next Q	-
EPS this Y	-
EPS next Y	-
EPS next 5Y	-
EPS past 3/5Y	73.72% 50.71%
Sales past 3/5Y	- -
EPS Y/Y TTM	99.51%
Sales Y/Y TTM	-
EPS Q/Q	92.08%
Sales Q/Q	-
Earnings	-
EPS/Sales Surpr.	- -

Insider Own	19.49%
Insider Trans	0.00%
Inst Own	4.52%
Inst Trans	13.42%
ROA	-272.48%
ROE	-620.63%
ROIC	-
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	-48.99%
SMA50	-73.28%
SMA200	-93.62%
Trades

Shs Outstand	1.02M
Shs Float	0.82M
Short Float	11.78%
Short Ratio	0.05
Short Interest	0.10M
52W High	136.29 -99.19%
52W Low	1.15 -3.48%
Volatility	16.79% 14.96%
ATR (14)	0.44
RSI (14)	27.06
Beta	0.79
Rel Volume	0.12
Avg Volume	2.07M
Volume	238,343

Perf Week	-38.33%
Perf Month	-66.57%
Perf Quarter	-79.44%
Perf Half Y	-91.09%
Perf YTD	-98.09%
Perf Year	-99.00%
Perf 3Y	-99.99%
Perf 5Y	-100.00%
Perf 10Y	-100.00%
Recom	-
Target Price	-
Prev Close	1.21
Price	1.11
Change %	-8.26%

Oct-01-26 05:15PM	Lokahi Therapeutics Expands University of Georgia Collaboration Through First International ai² Pipeline Project with Universitat Paderborn (Business Wire) -14.02% -14.18%
05:15PM	Lkahi Therapeutics Expands University of Georgia Collaboration Through First International ai Pipeline Project with Universitt Paderborn (Business Wire)
Sep-30-26 09:00AM	Lokahi Therapeutics Announces Qare, the First Real-Time Comparative Health Platform for GLP-1 Medications, with Public Availability Beginning October 14 (Business Wire) -5.75%
Sep-25-26 09:00AM	Lokahi Therapeutics Expands ai2 Pipeline Program Through Collaboration with Pepperdine E2B (Business Wire) -29.46%
09:00AM	Lkahi Therapeutics Expands ai2 Pipeline Program Through Collaboration with Pepperdine E2B (Business Wire)
08:45AM	Loading…
Sep-24-26 08:45AM	Glucotrack, Inc. Announces Pricing of $3 Million Public Offering (Business Wire) +27.09%
Sep-23-26 04:30PM	Lokahi Therapeutics Advances its Proprietary ai² PIPELINE (formerly ai² Futures Lab) Process from Internal Asset Engine to Revenue-Generating Platform (Business Wire) -8.56%
04:30PM	Lkahi Therapeutics Advances its Proprietary ai PIPELINE (formerly ai Futures Lab) Process from Internal Asset Engine to Revenue-Generating Platform (Business Wire)
09:00AM	Lokahi Therapeutics and Glucotrack CEO Erik Emerson Provides Strategic Update on LT-100, ai² Platform Growth and Clinical Development Priorities (Business Wire)
Sep-18-26 09:00AM	Lokahi Therapeutics Continues ai² Pipeline Division Collaboration with The University of Alabama to Advance Asset Evaluation and Biopharma Talent (Business Wire)
09:00AM	Lkahi Therapeutics Continues ai Pipeline Division Collaboration with The University of Alabama to Advance Asset Evaluation and Biopharma Talent (Business Wire)
Sep-11-26 08:00AM	Glucotrack Announces $11.5 Million Financing (Business Wire) -21.05%
Sep-08-26 09:15AM	Lokahi Therapeutics Expands ai² Into Three Opportunity-Creating Business Divisions (Business Wire)
09:15AM	Lkahi Therapeutics Expands ai Into Three Opportunity-Creating Business Divisions (Business Wire)
Sep-02-26 09:15AM	Lokahi Therapeutics Expands ai² Futures Lab Asset Origination Network Through Collaboration with San Diego State University Fowler College of Business (Business Wire)
08:00AM	Loading…
Aug-27-26 08:00AM	Glucotrack, Inc. Announces Reverse Stock Split (Business Wire) -10.87%
Aug-25-26 08:00AM	Lokahi Therapeutics Initiates Clinical Trial Manufacturing for LT-100 (Business Wire)
Aug-21-26 08:00AM	Lokahi Therapeutics Expands ai² Futures Lab Asset Origination Network Through Continued Collaboration with the University of Georgia (Business Wire)
Aug-17-26 10:51AM	Glucotrack Regains Nasdaq Equity Compliance as Strategic Transformation Advances (InvestorsHub) -6.91%
08:00AM	Glucotrack Achieves Key Compliance Milestone and Advances Strategic Transformation (Business Wire)
Aug-05-26 08:30AM	Glucotrack Announces $5.5 Million Financing (Business Wire) -12.30%
Jul-31-26 08:00AM	Lokahi Therapeutics ai² Futures Lab Changes How Biopharma Builds a Pipeline (Business Wire) -38.85%
08:00AM	Lkahi Therapeutics ai Futures Lab Changes How Biopharma Builds a Pipeline (Business Wire)
Jul-29-26 05:30PM	Lokahi Therapeutics Advances LT-100 Development Strategy Toward Single-Injection Administration (Business Wire) +173.68%
05:30PM	Lkahi Therapeutics Advances LT-100 Development Strategy Toward Single-Injection Administration (Business Wire)
Jul-17-26 08:05AM	Glucotrack, Inc. and Lokahi Therapeutics Announce Strategic Financing Support from E.F. Hutton & Co. in Connection with Their Recently Completed Business Combination and Future Capital Markets Initiatives (GlobeNewswire)
Jul-16-26 04:57PM	UPDATE - Glucotrack and Lokahi Therapeutics Complete Strategic Business Combination, Establishing Lokahi-Controlled Public Platform (GlobeNewswire) -5.48%
Jul-15-26 11:09AM	Glucotrack Completes Lokahi Therapeutics Business Combination, Creating AI-Driven Healthcare Platform (InvestorsHub)
11:09AM	Glucotrack Completes Lkahi Therapeutics Business Combination, Creating AI-Driven Healthcare Platform (InvestorsHub)
Jul-14-26 05:40PM	Glucotrack and Lokahi Therapeutics Complete Strategic Business Combination, Establishing Lokahi-Controlled Public Platform (GlobeNewswire) +14.13%
05:38PM	Loading…
Jul-08-26 05:38PM	Glucotrack Clears Key Milestone to Commercialize Its Implantable CGM (Exec Edge) +6.12%
08:00AM	Glucotrack Announces USPTO Notice of Allowance for Patent Application Covering Its Implantable CBGM Platform (GlobeNewswire)
May-26-26 08:00AM	Glucotrack to Highlight Implantable Continuous Blood Glucose Monitoring Technology at the American Diabetes Association's 2026 Scientific Sessions (GlobeNewswire) +18.92%
May-14-26 05:27PM	Glucotrack Reports First Quarter 2026 Financial Results and Recent Corporate Highlights (GlobeNewswire)
May-07-26 03:50PM	Glucotrack Submits Blood Glucose Monitoring Technology to FDA (Exec Edge)
01:00PM	Glucotrack Announces IDE Submission for U.S. Clinical Study of its Novel Implantable Continuous Blood Glucose Monitoring Technology (GlobeNewswire)
May-06-26 10:30AM	BC-Most Active Stocks (Associated Press) +16.92%
Apr-30-26 04:56PM	Glucotrack Shows Long-Term Accuracy of Implantable Glucose Monitor (Exec Edge) -7.26% -6.31%
09:00AM	Glucotrack Announces Publication of Peer-Reviewed Study In The Journal of Diabetes Research Demonstrating Long-Term Accuracy and Stability of Continuous Blood Glucose Monitoring Technology (GlobeNewswire)
Apr-29-26 10:30AM	BC-Most Active Stocks (Associated Press) +10.00%
Apr-21-26 11:59AM	Study Supports GlucoTracks Blood Glucose Monitoring Implant (Exec Edge)
08:00AM	Glucotrack Announces Publication of Peer-Reviewed Study Supporting Long-Life Sensor Design for Implantable Continuous Blood Glucose Monitoring Technology (GlobeNewswire)
Mar-30-26 04:50PM	Glucotrack Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Highlights (GlobeNewswire) -23.57% -14.11%
Mar-27-26 09:59PM	Glucotrack to File for FDA Exemption Based on 2025 Milestones (Exec Edge) -9.16%
08:01AM	Glucotrack to File Significant IDE with FDA for US Clinical Trial in Early Q2 Based on Critical 2025 Milestones (GlobeNewswire)
Mar-10-26 08:01AM	Glucotrack to Present at LSI USA '26 Medtech Innovation Summit (GlobeNewswire)
Jan-29-26 05:42PM	Glucotrack Announces 3 New Patents to Monitor Blood Glucose (Exec Edge) -33.43% -15.86%
08:01AM	Glucotrack Announces USPTO Approval for Issuance of Patents for Proprietary CBGM Platform (GlobeNewswire)
Dec-30-25 08:00AM	Glucotrack, Inc. Announces Pricing of $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules with a Single Institutional Investor (GlobeNewswire) -10.85%
Nov-13-25 04:05PM	Glucotrack Reports Third Quarter 2025 Financial Results and Provides Update on Recent Corporate Highlights (GlobeNewswire) -8.64%
Nov-03-25 04:05PM	Glucotrack, Inc. Encourages Shareholders to Vote (GlobeNewswire) -5.88%
Oct-29-25 04:05PM	Glucotrack Appoints Neuromodulation and Painful Diabetic Neuropathy Expert, Usman Latif, MD, MBA, to Clinical Advisory Team (GlobeNewswire) -11.64%
Oct-28-25 08:00AM	Glucotrack, Inc. Reminds Shareholders to Vote (GlobeNewswire) +9.94%
Sep-11-25 08:00AM	Glucotrack to Participate in the Q3 Virtual Investor Summit (GlobeNewswire) +5.18%
Sep-02-25 10:30AM	BC-Most Active Stocks (Associated Press Finance) +26.07%
Aug-14-25 04:05PM	Glucotrack Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights (GlobeNewswire)
Aug-06-25 08:30AM	Glucotrack Expands Clinical Advisory Team Appointing David S. Hirsh, MD as Medical Director, Cardiology (GlobeNewswire)
Jul-31-25 08:30AM	Glucotrack to Exhibit at 2025 Association of Diabetes Care and Education Specialists Annual Meeting (GlobeNewswire)
Jul-21-25 10:30AM	BC-Most Active Stocks (Associated Press Finance) +36.71%
Jul-08-25 08:30AM	Glucotrack Announces Repurchase of Series A Warrants (GlobeNewswire)
Jun-25-25 08:30AM	Glucotrack and OneTwo Analytics Present Positive Final Results of First-In-Human Study for Continuous Blood Glucose Monitor at American Diabetes Association's 85th Scientific Sessions (GlobeNewswire) +26.25%
Jun-12-25 09:05AM	Glucotrack Announces Reverse Stock Split Shareholder Approved Action Meets NASDAQ Panel Hearing Listing Requirements (GlobeNewswire) -33.81%
Jun-04-25 08:30AM	Glucotrack to Showcase Long-Term Continuous Blood Glucose Monitor at American Diabetes Association's 85th Scientific Sessions (GlobeNewswire)
May-28-25 08:30AM	Glucotrack Strengthens Board of Directors with Election of Victoria E. Carr-Brendel, PhD (GlobeNewswire)
May-20-25 08:30AM	Glucotrack Establishes Patient Advisory Board to Inform Diabetes Technology Development (GlobeNewswire)
May-14-25 05:10PM	Glucotrack Reports First Quarter 2025 Financial Results and Recent Corporate Highlights (GlobeNewswire)
10:23AM	Glucotrack gains HREC approval for clinical study of CBGM device (Medical Device Network)
May-13-25 08:01AM	Glucotrack Announces Ethical Approval for Long-Term Clinical Study of Continuous Blood Glucose Monitor (GlobeNewswire)
Apr-16-25 08:00AM	Glucotrack to Participate in FORGETDIABETES, a Prominent European Research Initiative to Develop a Bionic Pancreas (GlobeNewswire)
Apr-03-25 08:01AM	Glucotrack and OneTwo Analytics to Collaborate for Clinical Study Analysis on Its Continuous Blood Glucose Monitor (GlobeNewswire) -6.59%
Mar-31-25 05:00PM	Glucotrack Reports Full Year 2024 Financial Results and Recent Corporate Highlights (GlobeNewswire) -14.88% +28.94%
Mar-19-25 08:01AM	Glucotrack to Present First-In-Human Study Results for Continuous Blood Glucose Monitor at the 2025 International Conference on Advanced Technologies & Treatment for Diabetes (GlobeNewswire) +8.90%
Feb-26-25 08:01AM	Glucotrack Appoints Guillermo Umpierrez, MD, CDCES, FACE, MACP as New Medical Advisory Board Member (GlobeNewswire) +5.23%
Feb-05-25 11:52AM	Glucotrack Prices $3 Million Public Offering to Fund Expansion (GuruFocus.com) -12.47%
Feb-04-25 01:44PM	Glucotrack hits trial success for direct blood measuring CGM (Medical Device Network) -28.95%
12:24PM	Glucotrack, Inc. Announces Pricing of $3.0 Million Public Offering (GlobeNewswire)
08:01AM	Glucotrack Announces Successful Completion of Its First Human Clinical Study of Continuous Blood Glucose Monitor (GlobeNewswire)
Jan-30-25 08:00AM	Glucotrack Announces Reverse Stock Split (GlobeNewswire) -24.06%
Jan-29-25 09:00AM	Glucotrack Strengthens Leadership Team with Appointment of New Chief Financial Officer (GlobeNewswire)
Jan-21-25 08:01AM	Glucotrack Announces ISO 13485:2016 Certification (GlobeNewswire) +47.23%
Jan-15-25 08:01AM	Glucotrack Strenghtens Leadership Team with Addition of Industry Veteran as Vice President of Regulatory Affairs (GlobeNewswire) -35.25%
Jan-07-25 04:05PM	Glucotrack to Present at TechBio Showcase 2025 (GlobeNewswire) -10.45%
Dec-03-24 08:30AM	GLUCOTRACK ANNOUNCES START OF ENROLLMENT FOR HUMAN CLINICAL STUDY OF CONTINUOUS BLOOD GLUCOSE MONITOR (GlobeNewswire)
Nov-14-24 04:30PM	Glucotrack, Inc. Announces Closing of $10.0 Million Public Offering and Concurrent Private Placement Converting $4.0 in Outstanding Debt (GlobeNewswire) -14.33% -12.06%
Nov-13-24 09:00AM	Glucotrack, Inc. Announces Pricing of $10.0 Million Public Offering (GlobeNewswire) -77.06%
Oct-22-24 09:00AM	GLUCOTRACK TO PRESENT AT 2024 BIOFUTURE CONFERENCE (GlobeNewswire)
Oct-01-24 09:00AM	GLUCOTRACK ANNOUNCES ORAL & POSTER PRESENTATIONS AT THE 2024 DIABETES TECHNOLOGY MEETING (GlobeNewswire)
Sep-03-24 09:00AM	JOHN BALLANTYNE, FORMER BIOTECHNOLOGY EXECUTIVE, JOINS THE GLUCOTRACK BOARD OF DIRECTORS (GlobeNewswire)
Aug-27-24 09:00AM	GLUCOTRACK ANNOUNCES NEW VICE PRESIDENT OF CLINICAL OPERATIONS (GlobeNewswire)
Aug-15-24 09:00AM	Glucotrack's Innovative Blood Glucose Monitoring Concept Resonates with Patients with Diabetes, According to New Survey Presented at Association of Diabetes Care and Education Specialists (ADCES) 2024 Annual Conference (GlobeNewswire) +22.74%
Aug-05-24 09:00AM	GLUCOTRACK ANNOUNCES POSTER PRESENTATION ON CONTINUOUS BLOOD GLUCOSE MONITOR SURVEY DATA AT THE ASSOCIATION OF DIABETES CARE AND EDUCATION SPECIALISTS (ADCES) 2024 ANNUAL CONFERENCE (GlobeNewswire)
Jul-31-24 04:00PM	GLUCOTRACK ANNOUNCES NEW FUNDING FOR DEVELOPMENT OF ITS CONTINUOUS BLOOD GLUCOSE MONITOR (GlobeNewswire) -6.25% +10.00%
Jun-20-24 08:30AM	GLUCOTRACK ANNOUNCES THE APPOINTMENT OF ANDY BALO TO BOARD OF DIRECTORS (GlobeNewswire)
Jun-13-24 09:19AM	GLUCOTRACK REPORTS SUCCESSFUL COMPLETION OF FIRST REPORTED LONG-TERM PRECLINICAL STUDY OF ITS EPIDURAL GLUCOSE MONITORING SENSOR (GlobeNewswire)
Jun-11-24 10:50AM	Sidoti Events, LLC's Virtual June Small-Cap Conference (ACCESSWIRE) -7.19%
Jun-10-24 10:50AM	GLUCOTRACK TO PRESENT IN THE JUNE 2024 SIDOTI SMALL CAP CONFERENCE (GlobeNewswire)
Jun-05-24 08:30AM	GLUCOTRACK ANNOUNCES 90-DAY PRECLINICAL STUDY RESULTS THAT DEMONSTRATE SUSTAINED ACCURACY OF ITS IMPLANTABLE CONTINUOUS BLOOD GLUCOSE MONITOR (GlobeNewswire)
May-17-24 02:52PM	GCTK Stock Earnings: GlucoTrack Reported Results for Q1 2024 (InvestorPlace)
May-16-24 08:30AM	GLUCOTRACK'S EPIDURAL GLUCOSE MONITORING SENSOR DEMONSTRATES SUCCESSFUL 30-DAY SAFETY & PERFORMANCE IN LONG-TERM PRECLINICAL STUDY (GlobeNewswire)
May-15-24 04:15PM	GLUCOTRACK ANNOUNCES REVERSE STOCK SPLIT (GlobeNewswire) -10.20%

GlucoTrack, Inc. designs, develops, and commercializes non-invasive glucose monitoring devices for use by persons suffering from diabetes. The company offers the GlucoTrack model DF-F glucose monitoring device, which utilizes a patented combination of ultrasound, electromagnetic and thermal technologies to obtain glucose measurements. The company was founded by Avner Gal and David Malka in September 2001 and is headquartered in Rutherford, NJ.

Chief Technical Officer & PresidentDr. Paul V. Goode Ph.D.

CEO & DirectorMr. Erik C. Emerson

MSc.EEMr. Avner Gal MBA

Co-FounderMr. David Malka BA

Chief Operations OfficerMr. Vincent Wong

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

GCTK

GlucoTrack Inc

Upgrade your Finviz experience